Back to search
FDAFDA · Food and drugs·Recall number D-1355-2014

Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100-count bottle, Rx only. Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC., 20 Water view Blvd., Parsippany, NJ 07054, USA. NDC: 64679-736-02.

Published June 4, 2014 · Recall initiated: April 10, 2014

Summary

FDA records drug Class II recall D-1355-2014, published June 4, 2014 and initiated April 10, 2014. Recalling firm: Wockhardt Usa Inc.; Status: Terminated; Reported quantity: 8712 Bottles; Lot: Lot #: LN11423, Expiry: 8/15/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Failure of dissolution test observed at three month time point.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Wockhardt Usa Inc.
Distributor
Nationwide.
Lot
Lot #: LN11423, Expiry: 8/15/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100-count bottle, Rx only. Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC., 20 Water view Blvd., Parsippany, NJ 07054, USA. NDC: 64679-736-02. recalled?

Yes. FDA published recall D-1355-2014 on June 4, 2014. Reported hazard: Failed Dissolution Specifications: Failure of dissolution test observed at three month time point.

What should I do if I have this product?

Voluntary: Firm initiated · Letter